Intellivision buys 17.71% of CurveBeam AI for $2.6M
Intellivision Holdings of Singapore paid $2.6 million for a 17.71 percent voting stake in ASX-listed CurveBeam AI, disclosed through a filing with the Australian exchange.
Startup · $5m raised · Healthcare · AI
The company designs, manufactures, and markets CT scanners paired with AI-powered SaaS clinical tools that help healthcare professionals manage musculoskeletal disorders.
Melbourne, VIC
Every investor coverage indicates participated in a round CurveBeam AI raised.
Investors whose own portfolio pages list CurveBeam AI, even though we haven't found any coverage of the round yet.
| Investor | Listed on |
|---|---|
| Tenmile | its portfolio page ↗ |
Every published round CurveBeam AI took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
Companies CurveBeam AI has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| No portfolio companies recorded yet. | ||||
Fund closes reported for CurveBeam AI, as distinct from the investments it has made.
Companies CurveBeam AI has backed that another company then bought. An exit for the holding, not a deal CurveBeam AI did.
| Company | Bought by | Kind | Announced | Price |
|---|---|---|---|---|
| No portfolio company of CurveBeam AI is recorded as having been acquired. | ||||
Companies CurveBeam AI acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming CurveBeam AI. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Intellivision Holdings of Singapore paid $2.6 million for a 17.71 percent voting stake in ASX-listed CurveBeam AI, disclosed through a filing with the Australian exchange.
Medical imaging company CurveBeam AI completed a share purchase plan raising A$606,150, weeks after a A$5 million placement, with proceeds earmarked for sales, marketing, R&D and a planned China launch.
Medical imaging firm CurveBeam AI completed a A$5 million share placement aimed at big institutions and wealthy backers, and flagged a shareholder purchase plan to fund product development and commercialisation.
Also Dealroom
Techboard's September 2022 roundup reports Australian raises led by Morse Micro's $140m Series B, several acquisitions including ResApp Health to Pfizer, fund closes by Telstra Ventures, OIF and Main Sequence, and open raises.
Ignition Lane's weekly tech roundup covering fresh Australian startup raises, new venture funds and closes, a wave of acquisitions, delistings and a liquidation, executive moves, and Canva's product launch.
Also Techboard·Startup Daily